Please Wait.....
Report
Europe Monkeypox Testing Market - Industry Outlook and Forecast 2023-2025
Market Report I 2023-02-15 I 159 Pages I Arizton Advisory & Intelligence
The Europe monkeypox testing market was valued at USD 18,330.00 thousand in 2022 and is expected to reach USD 56.10 thousand by 2025.
KEY MARKET INSIGHTS
- Syndromic tests for monkeypox detection are expected to witness strong growth because they can distinguish monkeypox from other harmful diseases, allowing for easier treatment. On 25th May 2022, Roche and its subsidiary TIB Molbiol announced that they had developed a unique LightMix Modular Virus kit that simultaneously detects orthopoxvirus and offers information on whether an MPXV is present or not, including all MPXV from both the West African and Central African forms of the virus.
- Rapid tests in the Europe monkeypox testing market are also expected to witness strong growth due to their rapid results and increasing consumer preference.
- Demand for MPXV testing kits is expected to decline during the forecast as the cases can be seen declining due to increased surveillance, contact tracing, and increasing vaccination across Europe.
Increasing cases and testing are driving the growth of the Europe monkeypox testing market. The growing development of PCR kits as a standard gold method for monkeypox virus detection is propelling the growth of the market in the country. Also, increasing collaborations among In-Vitro Diagnostic (IVD) companies to develop and launch new monkeypox test kits is driving market growth. Surprisingly, the ease in medical device regulation only specific for monkeypox encouraged the IVD companies to bring new testing kits into the market and commercialize it, with PCR kits being the gold standard method. Confirmation of MPXV infection is based on nucleic acid amplification testing (NAAT), which uses conventional or real-time PCR to detect unique viral DNA sequences and is widely used as a standard method to detect MPXV. Increasing activities among vendors are driving the Europe monkeypox testing market growth, including the following:
- In July 2022, ELITechGroup, a France-based privately held manufacturer and distributor of IVD equipment, strategically partnered with Jiangsu Bioperfectus Technologies for monkeypox virus testing across Europe.
- In June 2022, Eurobio Scientific launched a CE-marked monkeypox screening test available for hospital use in France.
- On 8th June 2022, altona Diagnostics, a medical diagnostic company headquartered in Germany, announced the launch of the RealStar Zoonotic Orthopoxvirus PCR Kit 1.0, a real-time RT-PCR based reagent system for the detection of zoonotic (non-variola) Orthopoxvirus species-specific DNA - including MPVX DNA of the Central and West African strains.
- On 27th June 2022, Cepheid collaborated with the UK-based global molecular diagnostics company BioGX and announced a partnership between the two companies to provide a PCR test for MPX that will run on the GeneXpert system.
- In July, the altona Diagnostics company launched another monkeypox virus detection kit, Flexstar Monkeypox virus PCR Detection Mix 1.5, for research purposes.
- Bioactiva Diagnostica is another Germany-based company that offers PCR kits for monkeypox virus detection.
SEGMENT ANALYSIS
The growing product launches of lateral flow assay kits are expected to create lucrative opportunities for the Europe monkeypox testing market growth. Lateral flow assay is presently not preferred for monkeypox detection in the region because it may give false positive and negative results and because of its high cost. A number of rapid antibody and antigen test kits has been developed. Nanjing Synthgene Medical Technology, a China-based biomedical company, offers CE-certified rapid antibody and antigen tests at USD 1,253 and USD 438, respectively. In contrast, its MPXV Detection Kit (RT-PCR) costs around USD 144 with 24 tests, which means about USD 6 for each test.
Segmentation By Type
- PCR
- Lateral Flow Assay
- Others
The growing surveillance, contact tracing, and vaccine doses across the region are expected to impede market growth by a greater margin. However, it is unclear how much vaccine administrations have contributed to the slowdown in case numbers, and it is also unclear how long vaccine effects will last. In July 2022, the European Commission approved the MPX preventative vaccine, recommended by the European Medicines Agency (EMA).
Segmentation By End-User
- Laboratories
- Hospitals & Clinics
- Others
Bavarian Nordic, a global leader in smallpox vaccines, has been a long-term supplier of the Imvanex vaccine to the US Government and has already supplied the vaccine in the European Union (EU) to many different, often unnamed, European countries. Bavarian Nordic is focused on developing, manufacturing, and commercializing human vaccines. Imvanex vaccine has been authorized to protect adults from MPX disease in the EU since 22nd July 2022.
Since the time of vaccine approval, the region has been ramping up to supply vaccine doses to every country dealing with the highest number of cases. Vaccine administration and contact tracing have rapidly increased in Spain, the second country after the US, with the highest number of confirmed cases since June 2022. On 20th October 2022, National Health Service (NHS) launched a new online vaccine site finder to make it easy for eligible people to vaccinate.
REGIONAL ANALYSIS
In 2022, EU-5 accounted for the largest share of 77.71% in the Europe monkeypox testing market. In EU-5, Spain accounts for the highest revenue share, followed by France, UK, Germany, and Italy, which can be attributed to increasing cases, and increased testing. More than 98% of cases are identified in men who have sex with men in EU-5. The Netherlands is vaccinating high-risk people against MPX using two doses of the Imvanex smallpox vaccine. Until 3rd August 2022, 1,976 people in the Netherlands received a preventive vaccination against the MPXV.
In Berlin, Germany, vaccinations against the viral infection had begun in mid-July. In July, The Standing Commission on Vaccination (Stiko) recommended this for certain groups and people who have had close contact with infected persons. It sees an increased risk of infection, particularly among men who have same-sex sexual contact with changing partners. According to the Senate Department for Health, demand for the MPX vaccine is very high in Berlin; however, the vaccine is still in very short supply. The shortage in vaccine supply has increased the chances of spreading MPX, which implicitly increases the possibilities of the Europe monkeypox testing market growth. However, in the future, the growing number of vaccinations for monkeypox may hinder the growth of the MPX testing market. In addition, as the currently authorized vaccine, Imvanex is not authorized for children and pregnant women, the growth of MPX testing still holds growth opportunities during the forecast period. Also, an increase in risky behavior may cause a resurgence of the virus that may keep the opportunity for MPX testing market demand.
Segmentation By Region
- Europe
o EU-5
- Spain
- France
- UK
- Germany
- Italy
o Central, Eastern, and Southern Europe
- Netherlands
- Portugal
- Switzerland
o Nordic
- Sweden
- Denmark
VENDOR LANDSCAPE
- Hoffmann-La Roche
- Qiagen
- altona Diagnostics
- Autobio
- Applied DNA Sciences
- Aurora Biomed
- bioactiva diagnostica
- Beijing Hotgen Biotech
- BioGX
- CERTEST BIOTEC
- Creative Biogene
- CorDx
- CLONIT
- Eurobio Scientific
- FireGene
- GenScript
- Guangzhou Pluslife Biotech
- JOYSBIO (Tianjin) Biotechnology
- Nanjing Synthgene Medical Technology
- RayBiotech Life
- Sansure Biotech
- Virax Biolabs
- Wondfo
- Shanghai Biogerm Medical Technology
KEY QUESTIONS ANSWERED
How big is the Europe monkeypox testing market?
What is the projected growth rate of the Europe monkeypox testing market during the forecast period?
What are the growing trends in the Europe monkeypox testing market?
Which region holds the largest Europe monkeypox testing market share?
Which are the key players in the Europe monkeypox testing market?
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY TYPE
4.3.2 MARKET SEGMENTATION BY END-USER
4.3.3 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 OVERVIEW
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 DEVELOPMENT OF RAPID TESTING METHODS
9.2 ADVANCES IN PCR TECHNOLOGY
9.3 VENDOR COLLABORATIONS
10 MARKET GROWTH ENABLERS
10.1 INCREASED GOVERNMENT SURVEILLANCE
10.2 EASE OF REGULATIONS FOR PRODUCT APPROVALS
10.3 INCREASED PRODUCT LAUNCHES
11 MARKET RESTRAINTS
11.1 DECLINE IN MPX CASES
11.2 MPX VACCINE APPROVAL & ACCESS
11.3 FALSE MPX TEST RESULTS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 INSIGHTS BY TYPE
12.1.2 INSIGHTS BY END-USER
12.1.3 INSIGHTS BY GEOGRAPHY
12.2 FIVE FORCES ANALYSIS
12.2.1 THREAT OF NEW ENTRANTS
12.2.2 BARGAINING POWER OF SUPPLIERS
12.2.3 BARGAINING POWER OF BUYERS
12.2.4 THREAT OF SUBSTITUTES
12.2.5 COMPETITIVE RIVALRY
13 TEST TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 PCR
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.4 LATERAL FLOW ASSAYS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.5 OTHERS
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
14 END-USER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 LABORATORIES
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.4 HOSPITALS & CLINICS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.5 OTHERS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
15 GEOGRAPHY
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
16 EU-5
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.3 KEY COUNTRIES
16.3.1 SPAIN: MARKET SIZE & FORECAST
16.3.2 FRANCE: MARKET SIZE & FORECAST
16.3.3 UK: MARKET SIZE & FORECAST
16.3.4 GERMANY: MARKET SIZE & FORECAST
16.3.5 ITALY: MARKET SIZE & FORECAST
17 CENTRAL, EASTERN & SOUTHERN EUROPE
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 KEY COUNTRIES
17.3.1 NETHERLANDS: MARKET SIZE & FORECAST
17.3.2 PORTUGAL: MARKET SIZE & FORECAST
17.3.3 SWITZERLAND: MARKET SIZE & FORECAST
18 NORDICS
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 KEY COUNTRIES
18.3.1 SWEDEN: MARKET SIZE & FORECAST
18.3.2 DENMARK: MARKET SIZE & FORECAST
19 COMPETITIVE LANDSCAPE
19.1 COMPETITION OVERVIEW
19.2 MARKET SHARE ANALYSIS
19.2.1 F. HOFFMANN-LA ROCHE
19.2.2 QIAGEN
20 KEY COMPANY PROFILES
20.1 F. HOFFMANN-LA ROCHE
20.1.1 BUSINESS OVERVIEW
20.1.2 PRODUCT OFFERINGS
20.1.3 KEY STRATEGIES
20.1.4 KEY STRENGTHS
20.1.5 KEY OPPORTUNITIES
20.2 QIAGEN
20.2.1 BUSINESS OVERVIEW
20.2.2 PRODUCT OFFERINGS
20.2.3 KEY STRATEGIES
20.2.4 KEY STRENGTHS
20.2.5 KEY OPPORTUNITIES
21 OTHER PROMINENT VENDORS
21.1 ALTONA DIAGNOSTICS
21.1.1 BUSINESS OVERVIEW
21.1.2 PRODUCT OFFERINGS
21.2 AUTOBIO
21.2.1 BUSINESS OVERVIEW
21.2.2 PRODUCT OFFERINGS
21.3 APPLIED DNA SCIENCES
21.3.1 BUSINESS OVERVIEW
21.3.2 PRODUCT OFFERINGS
21.4 AURORA BIOMED
21.4.1 BUSINESS OVERVIEW
21.4.2 PRODUCT OFFERINGS
21.5 BIOACTIVA DIAGNOSTICA
21.5.1 BUSINESS OVERVIEW
21.5.2 PRODUCT OFFERINGS
21.6 BEIJING HOTGEN BIOTECH
21.6.1 BUSINESS OVERVIEW
21.6.2 PRODUCT OFFERINGS
21.7 BIOGX
21.7.1 BUSINESS OVERVIEW
21.7.2 PRODUCT OFFERINGS
21.8 CERTEST BIOTEC
21.8.1 BUSINESS OVERVIEW
21.8.2 PRODUCT OFFERINGS
21.9 CREATIVE BIOGENE
21.9.1 BUSINESS OVERVIEW
21.9.2 PRODUCT OFFERINGS
21.10 CORDX
21.10.1 BUSINESS OVERVIEW
21.10.2 PRODUCT OFFERINGS
21.11 CLONIT
21.11.1 BUSINESS OVERVIEW
21.11.2 PRODUCT OFFERINGS
21.12 EUROBIO SCIENTIFIC
21.12.1 BUSINESS OVERVIEW
21.12.2 PRODUCT OFFERINGS
21.13 FIREGENE
21.13.1 BUSINESS OVERVIEW
21.13.2 PRODUCT OFFERINGS
21.14 GENSCRIPT
21.14.1 BUSINESS OVERVIEW
21.14.2 PRODUCT OFFERINGS
21.15 GUANGZHOU PLUSLIFE BIOTECH
21.15.1 BUSINESS OVERVIEW
21.15.2 PRODUCT OFFERINGS
21.16 JOYSBIO (TIANJIN) BIOTECHNOLOGY
21.16.1 BUSINESS OVERVIEW
21.16.2 PRODUCT OFFERINGS
21.17 NANJING SYNTHGENE MEDICAL TECHNOLOGY
21.17.1 BUSINESS OVERVIEW
21.17.2 PRODUCT OFFERINGS
21.18 RAYBIOTECH LIFE
21.18.1 BUSINESS OVERVIEW
21.18.2 PRODUCT OFFERINGS
21.19 SANSURE BIOTECH
21.19.1 BUSINESS OVERVIEW
21.19.2 PRODUCT OFFERINGS
21.20 VIRAX BIOLABS
21.20.1 BUSINESS OVERVIEW
21.20.2 PRODUCT OFFERINGS
21.21 WONDFO
21.21.1 BUSINESS OVERVIEW
21.21.2 PRODUCT OFFERINGS
21.22 SHANGHAI BIOGERM MEDICAL TECHNOLOGY
21.22.1 BUSINESS OVERVIEW
21.22.2 PRODUCT OFFERINGS
22 REPORT SUMMARY
22.1 KEY TAKEAWAYS
22.2 STRATEGIC RECOMMENDATIONS
23 QUANTITATIVE SUMMARY
23.1 MARKET BY GEOGRAPHY
23.2 MARKET BY TYPE
23.3 MARKET BY END-USER
24 APPENDIX
24.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF EUROPE MONKEYPOX TESTING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 TESTING ALGORITHM FOR MPX VIRUS
EXHIBIT 4 IMPACT OF DEVELOPMENT OF RAPID TESTING METHODS
EXHIBIT 5 POPULAR RAPID TEST KITS
EXHIBIT 6 IMPACT OF ADVANCES IN PCR TECHNOLOGY
EXHIBIT 7 IMPACT OF VENDOR COLLABORATIONS
EXHIBIT 8 IMPACT OF INCREASED GOVERNMENT SURVEILLANCE
EXHIBIT 9 IMPACT OF EASE OF REGULATIONS FOR PRODUCT APPROVALS
EXHIBIT 10 IMPACT OF INCREASED PRODUCT LAUNCHES
EXHIBIT 11 IMPACT OF DECLINE IN MPX CASES
EXHIBIT 12 IMPACT OF MPX VACCINE APPROVAL & ACCESS
EXHIBIT 13 GLOBAL QUARTER SALES OF IMVANEX, 2022 ($ MILLION)
EXHIBIT 14 IMPACT OF FALSE MPX TEST RESULTS
EXHIBIT 15 GROWTH CURVE OF MPX CASES IN EUROPE AS OF NOVEMBER 7, 2022
EXHIBIT 16 PERCENT DISTRIBUTION OF DATA TYPE IN EUROPE AS OF NOVEMBER 9, 2022
EXHIBIT 17 EUROPE MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 18 EUROPE MONKEYPOX TESTING MARKET BY TYPE 2022-2025 (%)
EXHIBIT 19 EUROPE MONKEYPOX TESTING MARKET BY END-USER 2022-2025 (%)
EXHIBIT 20 EUROPE MONKEYPOX TESTING MARKET BY GEOGRAPHY 2022-2025 (%)
EXHIBIT 21 FIVE FORCES ANALYSIS 2022
EXHIBIT 22 INCREMENTAL GROWTH BY TYPE 2022 & 2025
EXHIBIT 23 EUROPE MONKEYPOX TESTING MARKET BY TYPE
EXHIBIT 24 EUROPE MONKEYPOX TESTING MARKET BY TYPE: INCREMENTAL GROWTH ($ THOUSAND)
EXHIBIT 25 EUROPE MONKEYPOX TESTING MARKET BY TYPE: ABSOLUTE GROWTH (%)
EXHIBIT 26 EUROPE MONKEYPOX TESTING MARKET BY PCR 2022-2025 ($ THOUSAND)
EXHIBIT 27 EUROPE MONKEYPOX TESTING MARKET BY PCR: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 28 EUROPE MONKEYPOX TESTING MARKET BY LATERAL FLOW ASSAYS 2022-2025 ($ THOUSAND)
EXHIBIT 29 EUROPE MONKEYPOX TESTING MARKET BY LATERAL FLOW ASSAYS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 30 EUROPE MONKEYPOX TESTING MARKET BY OTHERS 2022-2025 ($ THOUSAND)
EXHIBIT 31 EUROPE MONKEYPOX TESTING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 32 INCREMENTAL GROWTH BY END-USER 2022 & 2025
EXHIBIT 33 EUROPE MONKEYPOX TESTING MARKET BY END-USER
EXHIBIT 34 EUROPE MONKEYPOX TESTING MARKET BY END-USER: INCREMENTAL GROWTH ($ THOUSAND)
EXHIBIT 35 EUROPE MONKEYPOX TESTING MARKET BY END-USER: ABSOLUTE GROWTH (%)
EXHIBIT 36 EUROPE MONKEYPOX TESTING MARKET BY LABORATORIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 37 EUROPE MONKEYPOX TESTING MARKET BY LABORATORIES 2022-2025 ($ THOUSAND)
EXHIBIT 38 EUROPE MONKEYPOX TESTING MARKET BY HOSPITALS & CLINICS 2022-2025 ($ THOUSAND)
EXHIBIT 39 EUROPE MONKEYPOX TESTING MARKET BY HOSPITALS & CLINICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 NEW PRODUCT LAUNCHES
EXHIBIT 41 EUROPE MONKEYPOX TESTING MARKET BY OTHERS 2022-2025 ($ THOUSAND)
EXHIBIT 42 EUROPE MONKEYPOX TESTING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 43 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2025
EXHIBIT 44 EUROPE MONKEYPOX TESTING MARKET BY GEOGRAPHY
EXHIBIT 45 NUMBER OF MPX CASES IN EUROPEAN COUNTRIES AS OF NOVEMBER 9, 2022
EXHIBIT 46 EUROPE MONKEYPOX TESTING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ THOUSAND)
EXHIBIT 47 EUROPE MONKEYPOX TESTING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 48 EUROPE MONKEYPOX TESTING MARKET: KEY COUNTRIES 2022 ($ THOUSAND)
EXHIBIT 49 NUMBER OF MPX CASES IN EU-5 AS OF NOVEMBER 9, 2022
EXHIBIT 50 EU-5 MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 51 EU-5 MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 INCREMENTAL GROWTH IN EU-5 2022 & 2025
EXHIBIT 53 SPAIN MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 54 FRANCE MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 55 UK MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 56 GERMANY MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 57 ITALY MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 58 TOP COUNTRIES WITH MPX CASES IN CENTRAL, EASTERN & SOUTHERN EUROPE AS OF NOVEMBER 9, 2022
EXHIBIT 59 CENTRAL, EASTERN & SOUTHERN EUROPE MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 60 CENTRAL, EASTERN & SOUTHERN EUROPE MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 61 INCREMENTAL GROWTH IN CENTRAL, EASTERN & SOUTHERN EUROPE 2022 & 2025
EXHIBIT 62 NETHERLANDS MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 63 PORTUGAL MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 64 SWITZERLAND TOTAL MONKEYPOX CASES AS OF NOVEMBER 7, 2022
EXHIBIT 65 SWITZERLAND MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 66 TOP NORDIC COUNTRIES WITH MPX CASES AS OF NOVEMBER 9, 2022
EXHIBIT 67 NORDICS MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 68 NORDICS MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 69 INCREMENTAL GROWTH IN NORDICS 2022 & 2025
EXHIBIT 70 SWEDEN MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
EXHIBIT 71 DENMARK MONKEYPOX TESTING MARKET 2022-2025 ($ THOUSAND)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015-2022
TABLE 3 MOLECULAR TECHNIQUES FOR NUCLEIC ACID DETECTION
TABLE 4 IMMUNOLOGICAL METHODS FOR ANTIBODY OR ANTIGEN DETECTION
TABLE 5 TOTAL MPX CASES AMONG MEN FROM DIFFERENT CATEGORIES AS OF NOVEMBER 9, 2022
TABLE 6 RECENT MONKEYPOX TEST LAUNCHES
TABLE 7 SUMMARY OF MONKEYPOX CASES AS OF NOVEMBER 8, 2022
TABLE 8 NEWLY LAUNCHED PCR KITS WITH CE CERTIFICATION
TABLE 9 COMPANIES THAT OFFER LATERAL FLOW ASSAY KITS
TABLE 10 F. HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS
TABLE 11 QIAGEN: MAJOR PRODUCT OFFERINGS
TABLE 12 ALTONA DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 13 AUTOBIO: MAJOR PRODUCT OFFERINGS
TABLE 14 APPLIED DNA SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 15 AURORA BIOMED: MAJOR PRODUCT OFFERINGS
TABLE 16 BIOACTIVA DIAGNOSTICA: MAJOR PRODUCT OFFERINGS
TABLE 17 BEIJING HOTGEN BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 18 BIOGX: MAJOR PRODUCT OFFERINGS
TABLE 19 CERTEST BIOTEC: MAJOR PRODUCT OFFERINGS
TABLE 20 CREATIVE BIOGENE: MAJOR PRODUCT OFFERINGS
TABLE 21 CORDX: MAJOR PRODUCT OFFERINGS
TABLE 22 CLONIT: MAJOR PRODUCT OFFERINGS
TABLE 23 EUROBIO SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 24 FIREGENE: MAJOR PRODUCT OFFERINGS
TABLE 25 GENSCRIPT: MAJOR PRODUCT OFFERINGS
TABLE 26 GUANGZHOU PLUSLIFE BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 27 JOYSBIO (TIANJIN) BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 28 NANJING SYNTHGENE MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 29 RAYBIOTECH LIFE: MAJOR PRODUCT OFFERINGS
TABLE 30 SANSURE BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 31 VIRAX BIOLABS: MAJOR PRODUCT OFFERINGS
TABLE 32 WONDFO: MAJOR PRODUCT OFFERINGS
TABLE 33 SHANGHAI BIOGERM MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 34 EUROPE MONKEYPOX TESTING MARKET BY GEOGRAPHY 2022-2025 ($ THOUSAND)
TABLE 35 EUROPE MONKEYPOX TESTING MARKET BY GEOGRAPHY 2022-2025 (%)
TABLE 36 EUROPE MONKEYPOX TESTING MARKET BY TYPE 2022-2025 ($ THOUSAND)
TABLE 37 EUROPE MONKEYPOX TESTING MARKET BY TYPE 2022-2025 (%)
TABLE 38 EUROPE MONKEYPOX TESTING MARKET BY END-USER 2022-2025 ($ THOUSAND)
TABLE 39 EUROPE MONKEYPOX TESTING MARKET BY END-USER 2022-2025 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security